Federated Hermes’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.47M Sell
187,716
-417,076
-69% -$8M 0.01% 869
2026
Q1
$10.7M Buy
604,792
+33,324
+6% +$669K 0.02% 615
2025
Q4
$11.3M Buy
571,468
+126,283
+28% +$2.27M 0.02% 583
2025
Q3
$7.77M Sell
445,185
-149,304
-25% -$2.21M 0.01% 624
2025
Q2
$8.32M Buy
594,489
+13,206
+2% +$213K 0.02% 613
2025
Q1
$10.8M Buy
581,283
+48,728
+9% +$727K 0.02% 542
2024
Q4
$5.99M Buy
532,555
+132,635
+33% +$1.55M 0.01% 663
2024
Q3
$4.73M Buy
+399,920
New +$3.78M 0.01% 725
2024
Q2
Sell
-1
Closed -$5 2024
2024
Q1
$5 Buy
+1
New +$6 ﹤0.01% 2009
2022
Q2
Sell
-2
Closed -$1K 2134
2022
Q1
$1K Buy
+2
New +$18 ﹤0.01% 2057

Other funds holding ALHC

Federated Hermes's ALHC Position: Q2 2026 in Review

Federated Hermes reduced its Alignment Healthcare (ALHC) stake by 69% in Q2 2026, selling an estimated $8M and leaving 187,716 shares worth $4.47M. The position accounts for 0.01% of the portfolio, ranked #869.

Federated Hermes first reported a position in ALHC in Q1 2022 and has held it in 10 quarters since. The position peaked at $11.3M in Q4 2025. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Federated Hermes held 187,716 shares of Alignment Healthcare worth $4.47M as of Q2 2026.
  • Federated Hermes sold 417,076 Alignment Healthcare shares in Q2 2026, an estimated $8M.
  • Alignment Healthcare made up 0.01% of Federated Hermes's portfolio in Q2 2026, its #869 holding.
  • Federated Hermes first reported a position in Alignment Healthcare in Q1 2022 and has held it in 10 quarters since.
  • Federated Hermes's Alignment Healthcare position peaked at $11.3M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.